Nebivolol Actavis (Nebivolol Hydrochloride)

Nebivolol, the active ingredient in Nebivolol Actavis, is a beta blocker presented as an oral dosage form for oral use. It treats hypertension and heart failure in adult patients by lowering blood pressure and improving cardiac function. GNH USA supplies Nebivolol Actavis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nebivolol is a selective β1‑adrenergic blocker indicated for cardiovascular conditions that require blood pressure control or improved cardiac performance. - Hypertension: lowers systolic and diastolic blood pressure, reducing the risk of stroke and myocardial infarction. - Heart failure: enhances left‑ventricular ejection fraction and alleviates symptoms in patients with reduced cardiac output. - Left ventricular systolic dysfunction: improves cardiac contractility and functional capacity in patients with impaired systolic function.

Nebivolol may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Headache: mild to moderate intensity. - Dizziness or light‑headedness, especially on standing. - Fatigue or general weakness. - Bradycardia: slower than normal heart rate. - Nasal congestion or rhinorrhea. - Peripheral edema: mild swelling of ankles or feet.

Serious or Rare Side Effects: - Severe bradycardia or heart block requiring medical attention. - Acute bronchospasm in patients with asthma or chronic obstructive pulmonary disease. - Allergic reactions such as rash, pruritus, or angioedema. - Hepatic dysfunction or elevated liver enzymes. - Cardiogenic shock in susceptible individuals.

Before initiating Nebivolol therapy, clinicians should consider several safety measures. - Monitor blood pressure: ensure adequate reduction without hypotension. - Assess heart rate: watch for excessive bradycardia. - Caution in asthma or COPD: β1 selectivity may still affect bronchial tone. - Avoid abrupt discontinuation: taper to prevent rebound hypertension. - Use with caution in hepatic impairment: dose adjustment may be required. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nebivolol can interact with various medications, altering its efficacy or safety profile.

Major Interactions (Avoid): - Co‑administration with other beta‑blockers: risk of excessive bradycardia and hypotension. - Combined use with non‑dihydropyridine calcium channel blockers (verapamil, diltiazem): may cause severe conduction disturbances. - Potent CYP2D6 inhibitors (e.g., paroxetine, fluoxetine): increase nebivolol plasma concentrations.

Moderate Interactions (Monitor Closely):\n- Diuretics: may enhance antihypertensive effect, requiring blood pressure monitoring. - ACE inhibitors or ARBs: additive blood pressure lowering, watch for hypotension. - NSAIDs: may attenuate antihypertensive response, monitor renal function and blood pressure.